Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell TransplantationAdam Bryant, Christopher Bredeson, Sheryl McDiarmid et al.|JAMA Neurology|2016Cited by 103
Utility of Comorbidity Assessment in Predicting Transplantation-Related Toxicity Following Autologous Hematopoietic Stem Cell Transplantation for Multiple MyelomaLaura Labonté, David Allan, Tariq Iqbal et al.|Transplantation and Cellular Therapy|2008Cited by 55
Autologous Stem Cell Transplantation for Stiff Person SyndromeSheilagh Sanders, Harold Atkins, Christopher Bredeson et al.|JAMA Neurology|2014Cited by 46
Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantationGrace Christou, David Allan, Natasha Kekre et al.|Transfusion|2014Cited by 19
Health related quality of life for multiple myeloma patients according to treatment strategy after autologous stem cell transplant: a cross-sectional study using EORTC, EQ-5D and MY-20 scalesJason Tay, Arleigh McCurdy, Ravi Vij et al.|Leukemia & lymphoma/Leukemia and lymphoma|2018Cited by 10